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Abstract: Tropolone sesquiterpenoids (TS) are an intriguing
family of biologically active fungal meroterpenoids that arise
through a unique intermolecular hetero Diels–Alder (hDA)
reaction between humulene and tropolones. Here, we report on
the combinatorial biosynthesis of a series of unprecedented
analogs of the TS pycnidione 1 and xenovulene A 2. In
a systematic synthetic biology driven approach, we recombined
genes from three TS biosynthetic gene clusters (pycnidione 1,
xenovulene A 2 and eupenifeldin 3) in the fungal host
Aspergillus oryzae NSAR1. Rational design of the reconsti-
tuted pathways granted control over the number of hDA
reactions taking place, the chemical nature of the fused
polyketide moiety (tropolono- vs. monobenzo-pyranyl) and
the degree of hydroxylation. Formation of unexpected mono-
benzopyranyl sesquiterpenoids was investigated using isotope-
feeding studies to reveal a new and highly unusual oxidative
ring contraction rearrangement.
Introduction
Tropolone sesquiterpenoids (TS) are fungal meroterpe-
noid natural products[1] that display a significant array of
biological activities. For example: pycnidione 1 is an anti-
proliferative vs. human lung cancer cells (9 nM);[2] xenovu-
lene A 2 inhibits the human g-aminobutyrate A (GABAA)
benzodiazepine receptor (40 nM);[3] eupenifeldin 3 and neo-
setophome B 4 are potent antitumor agents (nanomolar
activity towards human cancer cell lines);[1,4] while epolone A
5 selectively induces erythropoietin (EPO) expression in
human cells in the mM range; (Scheme 1A).[5]
All tropolone sesquiterpenoids share the structural motif
of a core 11-membered macrocycle (derived from humulene
6 ; Scheme 1B) connected to one or two dihydropyran rings
that link the macrocycle with polyketide-derived tropo-
lones.[6] The structural diversity of TS is further enhanced
via: optional hydroxylation at the C-10 position (e.g. eupe-
nifeldin 3);[4] different olefin configurations of the central
humulene macrocycle (e.g. xenovulene B 11 vs. neoseto-
phome B 4);[6] replacement of one or two tropolone moieties
by monobenzopyranyl moieties (e.g. epolone A 5);[5] or
Scheme 1. A, Selected tropolone sesquiterpenoids with key structural
features highlighted. Red =polyketide derived tropolones; Blue= ben-
zopyranyl moiety; Green =optional C-10 hydroxylation; B, Hetero
Diels–Alder reaction in the biosynthesis of xenovulene B 11 and
neosetophome B 4 ; hDA = hetero Diels–Alderase; SDR= short-chain
dehydrogenase; P450= cytochrome P450.
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consecutive oxidative ring contractions of the polyketide (e.g.
xenovulene A 2).[7]
Successful total syntheses of known TS natural products
have not been reported in the literature,[8–11] suggesting that
a biosynthetic approach might be more feasible to access TS
scaffolds for biological testing.[6] Biosynthetically, TS are of
significant interest due to the unusual enzymology involved in
the formation of the core meroterpenoid skeleton.
Fungal biosynthetic gene clusters (BGC) have been
linked to the production of the two tropolone sesquiterpe-
noids xenovulene A 2 (aspks1 BGC in Sarocladium schorii =
Acremonium strictum) and eupenifeldin 3 (eup and eupf BGC
in Phoma sp. and Penicillium janthinellum, respectively).[6, 7,12]
TS biosynthesis proceeds via initial formation of stipital-
deyhde 8 by cooperation of a non-reducing PKS (nrPKS,
TropA), an FAD-dependent monooxygenase (FMO, TropB)
and a non-haem iron dioxygenase (NHI, TropC), analogous to
early biosynthetic steps in the biosynthesis of stipitatic acid
(Scheme 2 and Figure S14 in the Supporting Informa-
tion).[6, 7, 13]
Stipitaldehyde 8 represents a branching point in TS
biosynthesis (Scheme 1B): in the case of xenovulene A 2,
stipitaldehyde 8 is oxidised by the cytochrome P450 AsR2 to
the corresponding hemiacetal 9 and subsequent elimination
of water yields the reactive quino-methide 10 that undergoes
an enzyme-catalyzed hetero Diels–Alder reaction with a-
humulene 6, synthesised by an unusual terpene cyclase,
yielding xenovulene B 11 (Scheme 1B).[6, 7] However, during
the biosynthesis of eupenifeldin 3, stipitaldehyde 8 is reduced
by the short-chain dehydrogenase (SDR) EupfE to the
corresponding alcohol stipitol 12. The hetero Diels–Alderase
EupfF then catalyses formation of the o-quino-methide 13
prior to hetero Diels–Alder reaction with 10-hydroxy-humu-
lene 7, to give neosetophome B 4 (Scheme 1B).[6] Notably, in
vitro experiments with EupfF only gave rise to mono-
substituted tropolone sesquiterpenoids and formation of
bistropolones such as 1 and 3 has not yet been achieved in
vitro or in vivo.[6] Access to double hDA adducts thus
represents an intriguing biosynthetic challenge; similarly,
the origin and formation of TS natural products with benzene
Scheme 2. Biosynthetic routes towards tropolone sesquiterpenoids isolated in this study: A, each route representing an individual expression
experiment in A. oryzae NSAR1. Compounds in blue were newly isolated in this study. Compounds in brackets were not observed; B, Route to 6
and 24; C, incorporation of labelled sodium [1,2-13C2] acetate and (methyl-
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rings, such as epolone A 5,[1,14–17] has remained uninvestigated
so far.
We decided to deploy a synthetic biology driven combi-
natorial heterologous biosynthesis approach to rationally
expand the chemical space around TS natural products and to
investigate key biosynthetic steps. Aspergillus oryzae has
previously been established as an excellent host for the
expression of biosynthetic gene clusters[18–21] and recently we
reconstituted the total biosynthesis of the xenovulenes there-
in, granting rapid access to a variety of xenovulenes on
a multi-milligram scale.[7] We reasoned that rational extension
and diversification of the xenovulene A 2 biosynthetic
pathway by mixing and matching genes from different TS
BGC should give rise to new TS natural products and further
illuminate key biosynthetic steps in TS biosynthesis. Here, we
identify BGC involved in pycnidione 1 and eupenifeldin 3
biosynthesis and generate a series of new, unnatural TS
analogues. Labelling studies were deployed to investigate the
origin of monobenzopyranyl moieties observed in several
natural and unnatural compounds and the results shed light
on a new ring-contraction during their biosynthesis.
Results and Discussion
Phaeosphaeriaceae sp. CF-150626 and Leptobacillium sp.
CF-236968 were obtained from Fundaciln MEDINA (Gran-
ada, Spain). Phaeosphaeriaceae sp. (formerly referred to as
unidentified ascomycete F-150626) was previously reported
to produce the bistropolone-humulene eupenifeldin 3 and the
monotropolone-monobenzopyranyl-humulene noreupenifel-
din 14 (Figure 1C).[17] In our hands CF-150626 produced
eupenifeldin 3 (8.7 mgL@1; HRMS, [M]H+ calculated
C33H41O7 549.2852, found 549.2856) as the major product,
confirmed by full NMR characterization (Figure S24–S32 and
Table S10). A second compound, satisfying the molecular
weight of noreupenifeldin 14 (HRMS: [M]H+ calculated
C32H41O6 521.2903, found 521.2907) was also produced.
Purification to homogeneity (2.8 mgL@1) and NMR analysis
revealed slight differences in 1H- and 13C-NMR chemical
shifts as compared to noreupenifeldin 14.[17] Full structure
elucidation confirmed the compound to be a regioisomer of
noreupenifeldin in which the tropolone and benzene rings are
exchanged as compared to noreupenifeldin 14 (Figure S37–
S45 and Table S13). Subsequent comparison with literature
NMR data identified this compound as the previously
described noreupenifeldin B 15 (Figure 1A).[1] Dehydroxyeu-
penifeldin 16 (HRMS: [M]H+ calculated C33H40O6 533.2903,
found 533.2912; Figure 1A) was observed as a minor compo-
nent and characterized by NMR analysis (Figure S50–S57 and
Table S16).
The hitherto undescribed fungus CF-236968 produced
pycnidione 1 (2 mg; HRMS: [M]H+ calculated C33H41O7
549.2852, found 549.2853) as the dominant product, con-
firmed by full NMR characterization (Figure S58–S65 and
Table S17). Additionally, a related compound 17 with the
molecular weight of 520 (HRMS: [M]H+ calculated C32H41O6
521.2903, found 521.2905) was observed and purified to
homogeneity. Overall, the obtained NMR data was similar,
but not identical, to the previously reported epolone A 5.[5]
Analysis of COSY and HMBC data for 17 established the
carbon skeleton of the humulene, tropolone and monoben-
zopyranyl moieties (Figure S66–S73 and Table S18). Among
others, key HMBC/COSY correlations between H2-9’ and C-
6’ and between H-9’ to H-1 established the tropolone ring at
the western side of humulene; 1H-1H COSY coupling of H-8
to H2-8’’ together with
3J coupling of H2-8’’ to C-5’’ placed the
benzopyranyl moiety at the eastern side of humulene and
confirmed the regioselectivity of the fused ring-systems as
opposite to those encountered in epolone A 5, thus establish-
ing 17 as a novel TS that we name epolone C (Figure 1B).
Biosynthetic gene clusters involved in formation of
pycnidione 1 and eupenifeldin 3, were identified by standard
Illumina paired-end sequencing which afforded high quality
draft genome sequences for both fungi (e.g. CF-150626, 44.7
MBp and N50 164515; CF-236968 28.6 MBp and N50 466766;
Table S3). TS BGC were identified by search for nrPKS 3-
methylorcinaldehyde synthase (AsPKS1) homologs, since 3-
methylorcinaldehyde is the precursor of 8.[7] A single aspks1-
like gene cluster was revealed in each fungal genome (here
named eup2 BGC [CF-150626] and pyc BGC [CF-236968];
Figure 2A). The Artemis comparison tool was used to
visualize homologies between the two clusters and the
previously reported aspks1 BGC from Acremonium strictum
(Figure 2A).[23] As expected all clusters share core genes
necessary for stipitaldeyhde 8 formation (aspks1, asL1, asL3;
eupPKS, eupL1, eupL5; pycPKS, pycL1, pycL3 respectively)
and additionally homologous copies of a hetero Diels–
Alderase (asR5 ; eupR1; pycR1) and a humulene synthase
(asR6 ; eupR3 ; pycR6, Table S9).
Unique to the eup2 BGC and pyc BGC are short-chain
dehydrogenase encoding genes (eupL4 and pycL2 ; homolo-
gous to eupfE) and a cytochrome P450 (eupR6, pycR5)
homologous to eupfD, previously shown to be responsible for
C-10 hydroxylation of the terpene moiety.[6, 12] Noticeably, the
ring-contraction enzymes asL4 and asL6 only have a single
homologue in these clusters (eupR5 and pycR4 respectively).
Figure 1. A, tropolone sesquiterpenoids isolated from Phaeosphaeria-
ceae sp.; B, tropolone sesquiterpenoids isolated from Leptobacillium
sp.; C, Structure of noreupenifeldin 14.
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Comparison of the eup2 BGC to the previously reported
eup cluster in Phoma sp.[12] revealed a high degree of
similarity and this very strongly supported the eup2 cluster
to be responsible for the production of 3 in CF-150626.
(Table S9 and Figure S15). RT-PCR further confirmed upre-
gulation of the eup2 BGC only under 3-producing conditions
(Figure S16).
Pycnidione 1 has been isolated from several fungal
sources,[16, 24,25] but, to-date no biosynthetic gene cluster has
been reported. In order to link the putative pyc BGC to the
production of 1 we tried to genetically manipulate CF-236968.
However, the fungus proved resistant to common gene
disruption technologies. Furthermore, attempts to isolate
RNA from the fungus failed, preventing a similar analysis by
gene expression profiling as done for CF-150626. However,
the high degree of homology to the eup2 cluster and absence
of any other aspks1-like gene cluster in the genome strongly
supports the pyc BGC to be responsible for 1 formation.
Additionally, recombinant production of the putative humu-
lene synthase PycR6 and incubation with farnesylpyrophos-
phate afforded a-humulene 6 as confirmed by GC/MS
analysis (Figure S17–S19).
While fungal tropolone formation is well-understood, the
origin of the monobenzopyranyl moiety in noreupenifeldin B
15 and epolone C 17 poses an intriguing biosynthetic
question. Chen and co-workers as well as Zhang and co-
workers recently proposed a hetero Diels–Alder reaction
between humulene and an o-quinomethide (derived from
orsellinaldehyde) to explain the presence of the benzopyranyl
moiety.[26, 27] Orsellinaldehyde is a common fungal metabolite
and has been identified as the tetraketide product of an
nrPKS.[28] However, no biosynthetic evidence to support such
an hDA reaction has been reported so far. To establish the
biosynthetic origin of the benzopyranyl moiety we performed
incorporation studies with 13C-labelled acetates. In separate
experiments we fed CF-150626 with [1-13C]- and [2-13C]-
labelled acetates (Figure 2B). 13C-NMR of purified 3 showed
that 31/33 carbon signals were enhanced, and the obtained
labelling pattern of terpene and tropolone parts was identical
as previously reported for xenovulene B 11 (Figure S33–S36
and Table S11 + S12).[22] Only the NMR signals for carbons C-
3’ and C-3’’ (within the two tropolone rings) were not
enhanced, in agreement with their proposed origin from
methionine.[29]
In the case of noreupenifeldin B 15 30/32 carbon signals
were enhanced (Figure 2B). The observed pattern of label
incorporation in the tropolone and humulene was the same as
in eupenifeldin 3 : all carbon signals except the signal for C-3’
of the tropolone were enhanced (Figure S46–S49 and Ta-
ble S14 + S15). Surprisingly, carbons C-6’’ and C-1’’ were both
derived from [2-13C]-acetate, while the signal for C-2’’ was not
derived from acetate. This suggests that C-2’’ is derived from
methionine. C-6’’ and C-1’’ being both derived from [2-13C]-
acetate indicate that one acetate was disrupted during the
biosynthesis of the benzopyran moiety of noreupenifeldin B
15. A putative orsellinaldehyde precursor would show intact
labelling for four sequential intact acetate units and is thus
eliminated as a possible precursor to 15.
Contrary to previous suggestions, the labelling data
suggests that 15 is derived from a ring-contraction of
a tropolone precursor (probably eupenifeldin 3), instead of
originating from an hDA reaction between humulene and
a benzylic o-quinomethide. Notably, both the eup2 and pyc
BGC each include a gene homologous to asL4 and asL6
(eupR5, pycR4). AsL4 and AsL6 are FAD-dependent oxy-
genases known to catalyze regioselective oxidative ring
contractions during the biosynthesis of xenovulene A 2, and
thus represent possible candidates to catalyze such a reac-
tion.[7] Attempts to probe the role of PycR4, AsL4 and AsL6
in vitro were prevented in this study (and previously) by the
inability to obtain soluble protein preparations.[7] Further-
more, knockout and silencing experiments to probe the role
of these genes is not currently possible since the host
organisms cannot yet be transformed.
We next devised expression experiments in an attempt to
generate novel unnatural derivatives (Table 1). Previously we
reported on the heterologous production of xenovulene B 11
and xenovulene A 2 in A. oryzae NSAR by co-expressing six
or eight biosynthetic genes, respectively, using the modular
expression system established by Lazarus and co-workers
(Table 1, Exp. Xen B and Xen A respectively).[7,30] A series of
additional A. oryzae NSAR1 expression plasmids comprising
key biosynthetic genes from the eup2 and pyc BGC were
generated using standard yeast homologous recombination/
Figure 2. A, Artemis comparison between aspks1 BGC (Acremonium
strictum), eup2 BGC (Phaeosphaeriaceae sp.) and pyc BGC (Leptobacil-
lium sp.); B, isotopic labelling of key tropolone sesquiterpenoids with
sodium [1-13C, 2-13C, 1,2-13C2]-labelled acetate and/or [methyl-
13C]-
labelled methionine. Labelling pattern of xenovulene B 11 as described
by Simpson and co-workers.[22]
Angewandte
ChemieResearch Articles
23873Angew. Chem. Int. Ed. 2020, 59, 23870 – 23878 T 2020 The Authors. Published by Wiley-VCH GmbH www.angewandte.org
Gateway technology. Ectopic integration of biosynthetic
genes into A. oryzae NSAR1 gDNA was confirmed by PCR
analysis (Figure S5–S13).
We began by introducing modifications into the existing
biosynthetic route to xenovulene B 11. Hydroxylation at C-10
of a-humulene is a recurring feature in bistropolones[4, 25] but
has never been observed in the xenovulenes. Co-expression of
the xenovulene B 11 producing genes with the humulene
hydroxylase encoding gene eupR6 (Exp.1, Table 1) and
analysis by LCMS showed production of xenovulene B 11
and a new compound 18 (Figure 3, Exp. 1; Scheme 2A), with
a 16 amu difference relative to xenovulene B 11 (nominal
mass 382) as observed by HRMS ([M]H+ calculated C24H31O4
399.2171 found 399.2174). As expected, NMR structure
elucidation revealed the C-10 methylene observed in xeno-
vulene B 11 (dH 2.12/2.26; dC 38.0) to be replaced by
a downfield shifted oxygenated carbon (dH 4.36; dC 77.1) in
18 and confirmed 18 as 10-hydroxyxenovulene B (Figure S74–
S82 and Table S19). The relative stereochemistry of 18 was
determined by NOESY-NMR; absence of correlation be-
tween H3-12 and H-1 established these to be trans. H3-12
NOE correlation to H-9’, H2-3 and H2-11, but not H-10, places
H3-12 and OH-10 on the same face.
Surprisingly, inclusion of the ring-contraction encoding
genes asL4 and asL6 in the expression system (Exp. 2,
Table 1) led only to the production of xenovulene A 2
(Figure S20) but not to production of any hydroxylated
analogue of 2, suggesting that ring-contraction might out-
compete hydroxylation of the humulene moiety and that the
fully ring-contracted scaffold of xenovulene A 2 is not
a possible substrate for hydroxylation.
The known ring-contraction enzymes AsL4 and AsL6
from the aspks1 BGC show 34.8 % and 31.8% sequence
identity to EupR5 encoded in the eup2 cluster. Recently, Che
and co-workers proposed the EupR5 homologue EupH to be
a putative redox partner of the humulene hydroxylase present
in all eupenifeldin BGC.[12] However, the distinct sequence
homology of EupR5 to the known ring-contraction enzymes
AsL4 and AsL6 prompted us to hypothesise that EupR5
might catalyse a similar reaction in CF-150626—given the
observation of a ring-contraction during 15 biosynthesis.
To probe the biosynthetic role of EupR5 we co-expressed
the xenovulene B 11 producing genes with eupR5 in A. oryzae
(Exp. 3, Table 1). Analysis of transformants revealed the
formation of two compounds, 19 and 20, both having the
nominal mass of 370 (HRMS: [M]H+ calculated C23H31O4
371.2222 found 371.2218 and 371.2227; Figure 3; Exp. 3). A
12 amu difference compared to xenovulene B 11 (382) was
consistent with a ring contraction. Purification to homoge-
neity by preparative LCMS of both compounds individually
failed as the difference in retention time was too small.
However, NMR characterization of a mixture of 19 and 20
was sufficient to quickly identify 19 and 20 as the previously
reported products of AsL4 (19) and AsL6 (20, previously only
available in trace amounts) observed during the biosynthesis
of xenovulene A 2 (Scheme 2A, Figure S83-S92 and Table
S20).[7] Exp. 3 clearly demonstrates the ability of EupR5 to
catalyse oxidative ring-contractions in vivo.
Based on existing biosynthetic knowledge, the biosynthe-
sis of xenovulene A 2 and eupenifeldin 3 diverges after
formation of stipitaldehyde 8 (Scheme 1B). We hypothesised
that replacement of asR2 by the SDR gene eupL4 might
Table 1: Overview of performed heterologous expression experiments.
Exp. Xen. B and Xen. A previously reported.[7] PKS = polyketide synthase;
FMN= FAD-dependent monooxygenase; NHI = non-haem iron dioxy-
genase; P450 = cytochrome P450 monooxygenase; hDA = hetero Diels–
Alderase; Hum= humulene synthase; RC = ring-contraction enzyme;
SDR= short-chain dehydrogenase. Red shading =genes from aspks1
BGC; Blue shading =genes from pyc BGC; green shading = genes from
eup2 BGC. Red = isolated and fully characterised for the first time.
Figure 3. Heterologous expression of key biosynthetic gene combina-
tions in Aspergillus oryzae NSAR1. Shown are LC/MS diode array
(DAD) traces of extracts of representative transformants.
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redirect xenovulene A 2 biosynthesis in the direction of
mono- or bistropolones lacking the characteristic tetrahydro-
furan ring present in all xenovulenes (Exp.4, Table 1).
Analysis of transformants by LCMS analysis confirmed their
inability to produce any xenovulenes as was expected by
omission of asR2, halting the biosynthesis prior to the hDA
reaction. Instead, a single new compound 21 was produced in
excellent titres. HRMS analysis of 21 (HRMS: [M]H+
calculated C23H33O2 341.2481 found 341.2481) suggested
a molecular formula of C23H33O2. Surprisingly, the nominal
mass of 340 was too small to correspond to either a mono- or
bistropolone TS. Purification to homogeneity (3.4 mg) and
subsequent analysis by full NMR spectroscopy elucidated the
structure of 21.
Key tropolone NMR signals (e.g. characteristic aromatic
protons at 6.9–7.2 ppm; aromatic methyl singlet at 2.4 ppm;
carbonyl signal at 170 ppm) were replaced by aromatic
protons at 6.18 ppm (H-2’) and 6.25 ppm (H-6’) and together
with an aromatic methyl singlet at 2.19 ppm (H3-7’) indicated
substitution of the usual tropolone by a benzene. Key HMBC
correlations from H2-8’ to C-11, C-3’ and C-5’ respectively
further corroborated the structure of 21. Selective 1D-NOE
experiments confirmed absence of coupling between H3-12
and H-1 and, together with 2D-NOESY data, established the
relative stereochemistry at the humulene/dihydropyran ring
junction as trans, in agreement with biosynthetic consider-
ations (Figure S93–S103 and Table S21).
Further inclusion of the humulene hydroxylase gene
eupR6 in the expression system (Table 1, Exp. 5) led to
formation of two additional compounds (22, 23), both having
a nominal mass of 356 respectively (HRMS [M]H+ calculated
C23H33O3 357.2430 found 357.2428 (22) and 357.2431 (23))
consistent with 22 and 23 being hydroxylated derivatives of
21. Indeed, purification to homogeneity (2.8 mg, 4.4 mg) and
subsequent full NMR characterization revealed that the C-10
methylene group in 21 (dC 37.9 ppm; dH 1.83 and 2.10 ppm)
was replaced by downfield shifted oxygenated carbons in both
22 (dC 78.4 ppm; dH 3.99 ppm) and 23 (dC 73.9 ppm; dH
4.35 ppm, Figure S105–S131 and Table S23 + S24). 22 and 23
comprise the same structural skeleton as the previously
reported Pughiinin A, isolated from the fungus Kionochaeta
pughii BCC 3878.[16] However, small differences in 1H and
13C NMR shifts suggest 22 and 23 to be stereoisomers of
Pughiinin A. A series of 1D-NOE experiments was per-
formed to establish the relative stereochemistry of 22 and 23.
For 22, correlation of H-10 to H-1 and H-8’b and vice versa
suggested H-1, H-8’b and H-10 to be on the same face.
Absence of correlation from H3-12 to either H-1, H-10 or H-
8’b confirmed trans-fusion of the humulene/dihydropyran ring
(Figure 4). Compared to 22, compound 23 displayed signifi-
cant differences in 1H-NMR chemical shift: most notably both
H-10 (dH-10 4.35 ppm in 23 ; dH-10 3.99 ppm in 22) and H-1 (dH-
1 2.05 ppm in 22 ; dH-1 1.69 ppm in 23) were shifted downfield
by 0.36 ppm. Absence of nOe correlations between H3-12 and
H-1, H-10 and H-8’b confirmed trans-fusion of the humulene/
dihydropyran ring. Contrary to 22, H-10 did not correlate to
H-1 whereas H-1 still correlated to H-8’b and vice versa.
Together this nOe data suggests that in 23 the 10-hydroxy
moiety faces in the opposite direction as observed in 22. This
finding is further supported by careful comparison of 1H-
NMR shifts of H-1 in 1, 3, 15–21. Not surprisingly in all
compounds with H-1 and OH-10 on the same face dH-1 was
found to be > 2.00 ppm whereas in compounds with H-1 and
OH-10 on different faces dH-1 was typically found to be
< 1.90 ppm.
As a co-metabolite, humulene derivative 24 (Scheme 2B)
was concomitantly produced with 22 and 23 and purified to
homogeneity (4 mg; HRMS: [M-H2O]H
+ calculated C15H23O
219.1749 found 219.1749). NMR analysis confirmed 24 to be
the 1,2-epoxy-10-hydroxy derivative of humulene 6 (Fig-
ure S132–S140 and Table S25) and was similar to data
previously reported for phomanoxide (Figure S133).[31] Con-
trary to compound 24, phomanoxide harbours an additional
epoxide at C-4/C-5. We thus name compound 24 phoman-
oxide B. Interestingly, trace amounts of 22, 23 and 24 were
also observed in Exp. 4, lacking the co-expressed humulene
hydroxylase eupR6. Given the wealth of native cytochromes
P450 present in Aspergillus oryzae NSAR1 (ca. > 150) it
seems likely that a native oxygenase can hydroxylate the TS
scaffold albeit to a significantly lower degree.[32]
The results of experiments 1–5 (Table 1) demonstrated
the feasibility to engineer the biosynthesis of xenovulenes,
resulting in the successful generation of 18–24. Notably,
despite introduction of humulene hydroxylase EupR6, and
short-chain dehydrogenase EupL4, all transformants solely
produced mono-substituted Diels–Alder adducts, suggesting
that the xenouvlene A 2 hDA enzyme AsR5 is limited in
regard to the number of hDA reactions it catalyses. We
reasoned that exchange of AsR5 for an hDA enzyme from the
eupenifeldin (EupR1) or pycnidione (PycR1) pathway might
redirect the pathway to the production of bistropolones.
However, omission of asR2 and replacement of asR5 and
asR6 for eupR1 and eupR3 did not lead to production of any
tropolone sesquiterpenoids (Table 1, Exp. 6; Figure S21).
Further inclusion of short-chain dehydrogenase encoding
Figure 4. Structure elucidation of 22 and 23. See Supporting Informa-
tion for detailed structure elucidation of all other compounds. 3D
model structures of 22 and 23 were calculated using Spartan 18 and
minimised using molecular mechanics.
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gene eupL4 (Table 1, Exp. 7; Figure S22) and humulene
hydroxlyase eupR6 and FAD-dependent monooxygenase
eupR5 (Table 1, Exp. 8; Figure S23) in the expression also
did not lead to production of the desired meroterpenoids.
Omission of asR2 and introduction of hetero Diels–
Alderase and terpene cyclase encoding genes pycR1 and
pycR3 from the pycnidione pathway instead of eupR1 and
eupR3 proved more successful (Exp. 9). Analysis of trans-
formants by LCMS analysis identified the production of two
new compounds (25, 26) compared to a WT control (Fig-
ure 3). The nominal mass (532, Figure S142) and UV spec-
trum of minor component 25 was consistent with a bistropo-
lone lacking the C-10 hydroxyl group. Indeed, purification of
compound 25 and NMR characterization established the
structure of 25 (Figure S141–S147; Table S26): key aromatic
1H-NMR signals at 7.33/7.27/7.17/7.15 ppm together with two
aromatic methyl group signals at 2.50 ppm and 2.43 ppm were
characteristic for the presence of two tropolone rings. Key
COSY and HMBC correlations further confirmed the struc-
ture of 25.
Purification of major component 26 to homogeneity
afforded 4 mg ([M]H+ calculated C32H41O5 505.2954 found
505.2941) and subsequent NMR analysis confirmed its
structure. Key tropolone NMR signals including aromatic
protons at 7.08 ppm and 7.22 ppm and a methyl singlet at
2.41 ppm established the presence of one tropolone ring; key
HMBC correlations from H2-9’’ to C-7, C-9, C-4’’ and C-6’’
placed the tropolone ring at the eastern side of humulene.
Additional aromatic proton signals at 6.14 and 6.25 ppm
together with an aromatic methyl group at 2.21 ppm con-
firmed replacement of the second tropolone ring by a ben-
zene. HMBC correlations of H2-8’ to C-2, C-11, C-3’ and C-5’
further corroborated the structure and placed the benzene
ring at the western face of humulene (Figure S148-S156 and
Table S27). Absence of NOESY correlations between H-
1 and H3-12 as well as between H-8 and H3-15 together with
other NOESY correlations established the relative stereo-
chemistry at the ring-junctions to be trans, in agreement with
biosynthetic considerations.
Surprisingly, both Exp. 4 and Exp. 9 afforded TS natural
products (21, 26) with a benzene ring instead of the expected
tropolone moiety, despite the reconstituted pathways con-
taining no ring-contraction enzyme. In order to establish the
biosynthetic origin of these 6-membered rings in A. oryzae we
performed labelling experiments using [1,2-13C2]-labelled
acetate. Labelled 21 and 26 were analysed by 13C-NMR
(Figure S104 + S157–S158 and Table S22 + S28). Analysis of
coupling constants quickly identified integration of intact
acetate units. For both compounds the labelling pattern of the
benzopyranyl moieties were identical, comprising three intact
acetate units (C7’-C5’, C6’-C1’ and C4’-C8’). Instead of a fourth
intact acetate unit, both C-2’ and C-3’ did not show coupling
to any other carbon atom. We reasoned that the obtained
labelling pattern was in agreement with the six-membered
ring in 21 and 26 being derived from a ring-contraction of
a tropolone precursor, resulting in rearrangement of one
acetate unit and C-2’ to be derived from methionine. To probe
this hypothesis, we fed [methyl-13C]-labelled methionine to
the 26 producing strain.
Purification of labelled 26 and subsequent analysis by 13C-
NMR showed signal enhancement for two carbon signals,
corresponding to C-3’’ (within the tropolone ring) and C-2’
(within the benzene ring, Figure S159–S161). The obtained
labelling pattern thus demonstrates that 26 (and 21 accord-
ingly) are derived from a ring-contraction of a tropolone
precursor—it is therefore highly likely that 26 is derived from
25. Benzopyran 21 is therefore most likely derived from an
unobserved tropolonopyran precursor 27 (Scheme 2A).
Significantly, the labelling pattern of the six-membered
ring in 21 and 26 differs from labelling pattern of the six-
membered ring in noreupenifeldin B 15 (Scheme 3). For 21
and 26, ring contraction in A. oryzae must proceed via
excision of the C-2’ carbon in 27 and 25 respectively, whereas
ring contraction of 3 in CF-150626 must proceed via excision
of the C-1’’ (Scheme 3A). In the absence of a transformed
ring-contraction enzyme in Exp. 5 and Exp. 9 we reasoned
that Aspergillus oryzae NSAR1 itself must contain a putative
ring-contraction enzyme, but the identity of this enzyme
remains unknown. Notably, the ring-contraction by A. oryzae
is only observed for compound 21 and 26 but not for
xenovulene B 11, which is stable in A. oryzae albeit it also
comprises an intact tropolone ring. Structurally, xenovulene B
11 differs from 21 and 26 by the tetrahydrofuran ring
characteristic of all xenovulenes and it appears that the
putative ring-contraction enzyme in A. oryzae does not accept
these as substrates. Furthermore, the observed ring-contrac-
tions in A. oryzae and also in Phaeosphaeriaceae sp. appear to
be highly regioselective as in A. oryzae only tropolone rings
on the western face of humulene are contracted whereas in
Phaeosphaeriaceae sp. the ring-contraction occurs on the
eastern side of humulene. These ring contractions also differ
from those observed to be performed by AsL4 and AsL6 in
the xenovulene pathway, and EupR5 observed here
(Scheme 2). AsL4, AsL6 and EupR5 catalyse an oxidative
ring contraction which leaves a hydroxyl group on the
benzene ring, for example, 19 and 20, whereas 15, 21 and 26
do not contain additional oxygen.
We previously suggested a mechanism which would
explain the retention of oxygen (Scheme 3C) in the case of
xenovulene A 2 biosynthesis.[7] It is possible that the
production of 15, 21 and 26 could proceed via a similar
mechanism to 19 and 20, followed by a reductive step.
However, we did not observe any intermediates which might
support this possibility. Alternatively, a different FAD-
dependent mechanism could be in play (Scheme 3D), involv-
ing a ring-opening-ring-closing sequence which would explain
the observed labelling and oxygenation patterns in A. oryzae.
A similar mechanism involving initial attack at C-2’’ of 3
would explain the observed labelling pattern in 15. Tropolone
ring-opening mechanisms have been suggested during the
biosynthesis of phomanolides C-F.[27] Chemical investigations
by Ito support the initial oxidative ring expansion in this
possibility.[33] However, in the absence of additional informa-
tion the precise origin and mechanism of these new trans-
formations remains to be determined.
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Conclusion
Here, we report on the identification of the eup2 and pyc
BGC, responsible for formation of eupenifeldin 3 and
pycnidione 1 in CF-150626 and CF-236968 for the first time.
We successfully engineered A. oryzae NSAR1 for the
heterologous production of seven new unnatural tropolone
sesquiterpenoids in good yields, by exploiting a systematic
combinatorial biosynthesis approach, demonstrating the
power of heterologous expression in fungi for the rational
creation of new compounds. In this case synthetic biology out-
performs synthetic chemistry which has not yet been used for
the synthesis of these or related natural products. Further-
more, the heterologous expression system deployed was
successfully used to determine the biosynthetic function of
proteins with previously unknown activity (e.g. EupR5). This
work also shows that the hDa enzymes differ in their ability to
produce mono (e.g. AsR5) and di-tropolone (e.g. PycR1)
meroterpenoids. We also showed that benzopyranyl moieties
are derived via a ring-contraction of a tropolone precursor
instead of the previously suggested hDA reaction with an
orsellinaldehyde. Surprisingly, Aspergillus oryzae NSAR1 is
capable of catalyzing a similar ring-contraction, although the
conducted labelling studies demonstrate, that the mechanism
must differ from that previously observed during the biosyn-
thesis of xenovulene A catalysed by AsL4/AsL6, or by
EupR5. Given the wealth of potent biological activity present
in naturally occurring TS natural products, this work paves
the way to systematically assess TS natural products and to
construct a compound library to be tested for additional/
improved biological activity.
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